Neogen Chemicals Limited
NEOGEN CHEMICALS has recommended a final dividend of Rs.0.1 per equity share for the financial year FY26. The record date for the dividend will be fixed later. The board approved this during its meeting on May 16, 2026.
May 16 2026 21:05:00
Neogen Chemicals Limited
NEOGEN CHEMICALS has recommended a final dividend of Rs.0.1 per equity share for the financial year FY26. The record date for the dividend will be fixed later. The board approved this during its meeting on May 16, 2026.
May 16 2026 21:05:00
Neogen Chemicals Ltd - 542665 - Outcome Of Board Meeting
Neogen Chemicals' Board approved its Q4 and FY26 financial results, declared a Rs.1 final dividend, updated on project timelines and increased costs for Dahej and Pakhajan, and noted an improved credit rating outlook.
May 16 2026 21:05:00
Neogen Chemicals Ltd - 542665 - Board Meeting Intimation for To Consider And Approve Audited Financial Results And Recommendation Of Final Dividend, If Any, Subject To Approval Of Shareholders.
Neogen Chemicals' Board of Directors will meet on May 16, 2026. The agenda includes approving the Q4 FY26 and full-year financial results, along with considering a final dividend recommendation for shareholders.
May 12 2026 12:05:00
Neogen Chemicals Ltd - 542665 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Neogen Chemicals' promoter, Dr. Harin Haridas Kanani, pledged 13.19 lakh equity shares, representing 5% of the company's paid-up capital. This action facilitates borrowing for Cadamba Solutions Private Limited, a promoter group member.
Apr 30 2026 10:04:00
Neogen Chemicals Ltd - 542665 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Neogen Chemicals promoter Dr. Harin Haridas Kanani pledged an additional 20.19 lakh equity shares, equivalent to 7.65% of the company's paid-up capital. This action was taken to facilitate fund-raising for Cadamba Solutions Private Limited, a promoter group member.
Apr 29 2026 19:04:00
Neogen Chemicals Limited
Neogen Chemicals' subsidiary, Neogen Ionics, approved subscribing to 7.1 million equity shares of its step-down subsidiary, Neogen Morita New Material, for ₹100.11 crores through a rights issue. This capital infusion, priced at ₹141 per share, will support Neogen Morita's CAPEX/OPEX and address growth opportunities in the Lithium-ion Battery material space, particularly for electrolyte salts.
Apr 28 2026 18:04:00
Read More